Postgraduate Medicine

Papers
(The H4-Index of Postgraduate Medicine is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Associations of serum calcium/magnesium ratios with coronary artery disease in diabetes: a cross-sectional study133
Eosinophilic granulomatosis with polyangiitis118
Unlocking the diagnostic potential of parathormone washout: a path to accurate parathyroid tumor localization96
A different outlook to consequences of anemia in older adults68
Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years48
Introduction to Hospital Medicine43
Reliability of transcutaneous hemoglobin measurements in an outpatient pediatric clinic43
Junctional ectopic tachycardia revisited42
A randomized controlled trial concerning the implementation of the postural Mézières treatment in elite athletes with low back pain34
Updates in the diagnosis and management of Takayasu’s arteritis32
Exploring the wider benefits of semaglutide treatment in obesity: insight from the STEP program31
Impact of chronic medications in the perioperative period –anesthetic implications (Part II)30
LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals29
Effect of berberine and bicyclol on Chinese patients with nonalcoholic fatty liver disease: a retrospective study27
Abstracts from the 19th Annual Cardiometabolic Health Congress26
Cardiometabolic risk factors efficacy of semaglutide in the STEP program25
Plasma: indications, controversies, and opportunities23
The cardiovascular effects of large hiatal hernias: a narrative review of cases and studies23
Association between serum vitamin C and chronic kidney disease among adults in NHANES, 2017-201820
Role of RAGE and its ligand HMGB1 in the development of COPD19
0.05778694152832